Insulin granule recruitment and exocytosis is dependent on p110gamma in insulinoma and human beta-cells

Diabetes. 2009 Sep;58(9):2084-92. doi: 10.2337/db08-1371. Epub 2009 Jun 23.

Abstract

Objective: Phosphatidylinositol 3-OH kinase (PI3K) has a long-recognized role in beta-cell mass regulation and gene transcription and is implicated in the modulation of insulin secretion. The role of nontyrosine kinase receptor-activated PI3K isoforms is largely unexplored. We therefore investigated the role of the G-protein-coupled PI3Kgamma and its catalytic subunit p110gamma in the regulation of insulin granule recruitment and exocytosis.

Research design and methods: The expression of p110gamma was knocked down by small-interfering RNA, and p110gamma activity was selectively inhibited with AS605240 (40 nmol/l). Exocytosis and granule recruitment was monitored by islet perifusion, whole-cell capacitance, total internal reflection fluorescence microscopy, and electron microscopy in INS-1 and human beta-cells. Cortical F-actin was examined in INS-1 cells and human islets and in mouse beta-cells lacking the phosphatase and tensin homolog (PTEN).

Results: Knockdown or inhibition of p110gamma markedly blunted depolarization-induced insulin secretion and exocytosis and ablated the exocytotic response to direct Ca(2+) infusion. This resulted from reduced granule localization to the plasma membrane and was associated with increased cortical F-actin. Inhibition of p110gamma had no effect on F-actin in beta-cells lacking PTEN. Finally, the effect of p110gamma inhibition on granule localization and exocytosis could be rapidly reversed by agents that promote actin depolymerization.

Conclusions: The G-protein-coupled PI3Kgamma is an important determinant of secretory granule trafficking to the plasma membrane, at least in part through the negative regulation of cortical F-actin. Thus, p110gamma activity plays an important role in maintaining a membrane-docked, readily releasable pool of secretory granules in insulinoma and human beta-cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Calcium Channels / physiology
  • Cell Line, Tumor
  • Class Ib Phosphatidylinositol 3-Kinase
  • Exocytosis / physiology
  • Humans
  • Insulin / metabolism*
  • Insulin Secretion
  • Insulin-Secreting Cells / cytology*
  • Insulin-Secreting Cells / metabolism*
  • Insulinoma
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • Membrane Potentials / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Pancreatic Neoplasms
  • Patch-Clamp Techniques
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Quinoxalines / pharmacology
  • RNA, Small Interfering
  • Secretory Vesicles / metabolism*
  • Thiazolidinediones / pharmacology

Substances

  • 5-quinoxalin-6-ylmethylenethiazolidine-2,4-dione
  • Actins
  • Calcium Channels
  • Insulin
  • Isoenzymes
  • Phosphoinositide-3 Kinase Inhibitors
  • Quinoxalines
  • RNA, Small Interfering
  • Thiazolidinediones
  • Class Ib Phosphatidylinositol 3-Kinase
  • PIK3CG protein, human
  • Pik3cg protein, mouse